Protein– tag –
-
Insilico Medicine Advances AI-Designed Drug to Phase III for IPF, with 31 Candidates Beyond Preclinical Stage
Forbes USA Overview Generative biology, leveraging AI to design drug molecules, proteins, and DNA, is pushing AI-designed candidates into human trials. Insilico Medicine has a Phase III drug for idiopathic pulmonary fibrosis and 31 devel... -
China’s AsymBio Secures $184M to Dramatically Expand Biologics CDMO Capacity, Bolstering ADC Production
PharmaSource China Overview AsymBio, a Chinese biologics CDMO, secured approximately $184 million (1.2397 billion Yuan) in financing to substantially expand its manufacturing capacity, R&D capabilities, GMP manufacturing lines, and h... -
CDMOs Boost Sterile Fill-Finish and Prefilled Syringe Capacity by Over $1 Billion to Meet Biologics and GLP-1 Drug Demand
BioProcess International USA Overview Contract Manufacturing and Development Organizations (CMOs/CDMOs) are making multi-billion dollar investments, including PCI Pharma Services' global $1 billion expansion, to significantly increase st... -
Roche’s Cevostamab Achieves 42.1% ORR in Phase 1 for Relapsed/Refractory Multiple Myeloma
OncLive USA Overview Roche's investigational FcRH5 x CD3 bispecific antibody cevostamab (RG6160) demonstrated an overall response rate (ORR) of 42.1% across all dose levels (n=324) in a Phase 1 trial for relapsed/refractory multiple myel... -
Generative AI Revolutionizes Pharmaceutical Research: Accelerating Drug Discovery from Years to Months
Generative AI in Drug Discovery USA Overview Generative AI is profoundly transforming pharmaceutical research, primarily through de novo drug design, protein structure prediction, and biologics design. It enables the computational genera... -
Adaptyx Biosciences Unveils AI-Powered Luminescent Biosensor for Smartphone-Based, Hospital-Grade Cortisol Detection
IEEE Spectrum USA Overview Biotech startup Adaptyx Biosciences, in collaboration with UC Santa Cruz, has developed an AI-powered luminescent protein-based biosensor for detecting cortisol in blood or urine. This innovative device binds w... -
Drexel University Develops Novel Hydrogel to Enhance Graphene-Based Biosensors: Driving Early Cancer Detection and Real-Time Monitoring
Facebook (EurekAlert!) USA Overview Researchers at Drexel University have developed a novel hydrogel that significantly improves graphene-based biosensor technology. By incorporating graphene quantum dots (GQDs), this hydrogel achieves h... -
Electrochemical and Electrical Biosensors Pioneer Alzheimer’s Disease Early Diagnosis: Achieving Ultrasensitive Aβ42 Detection
MDPI International Overview Electrochemical and electrical biosensors are opening new possibilities for detecting blood protein biomarkers of Alzheimer's Disease (AD). Notably, a biosensor using a PdNP (palladium nanoparticle)-modified e... -
AI/Machine Learning Integrated Aptasensing Achieves Significant Gains in Diagnostic Efficiency and Accuracy, Accelerating Early Detection, Precision Medicine, and POC Applications
ACS Publications International Overview Aptamer-based biosensing (aptasensing) technology has achieved substantial improvements in diagnostic efficiency and accuracy through the innovative integration of Artificial Intelligence (AI) and ... -
Hydrogel-Forming Microneedles Enable Minimally Invasive Monitoring of Diverse Interstitial Fluid Biomarkers and Therapeutic Drugs
ACS Publications USA Overview Hydrogel-Forming Microneedles (HFMNs) are emerging as a minimally invasive interface for biosensing and therapeutic drug monitoring via interstitial fluid (ISF). This technology has expanded from initial glu...
